Terra Nova Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Sell
7,450
-131
-2% -$32.6K 1.24% 38
2025
Q4
$1.83M Sell
7,581
-224
-3% -$57.3K 1.2% 37
2025
Q3
$2.14M Buy
7,805
+46
+0.6% +$12.6K 1.35% 31
2025
Q2
$2M Sell
7,759
-191
-2% -$45.6K 1.4% 32
2025
Q1
$1.78M Buy
7,950
+52
+0.7% +$12.1K 1.4% 33
2024
Q4
$1.81M Buy
7,898
+41
+0.5% +$9.87K 1.38% 33
2024
Q3
$1.92M Sell
7,857
-155
-2% -$34.6K 1.42% 32
2024
Q2
$1.53M Buy
8,012
+3,954
+97% +$802K 1.21% 36
2024
Q1
$804K Sell
4,058
-457
-10% -$83.7K 0.64% 47
2023
Q4
$777K Sell
4,515
-2,845
-39% -$437K 0.68% 49
2023
Q3
$1.61M Hold
7,360
1.46% 30
2023
Q2
$1.61M Buy
7,360
+258
+4% +$57.5K 1.46% 30
2023
Q1
$1.56M Buy
7,102
+301
+4% +$65.3K 1.52% 24
2022
Q4
$1.42M Sell
6,801
-130
-2% -$28.6K 1.48% 28
2022
Q3
$1.51M Buy
6,931
+113
+2% +$25.7K 1.65% 24
2022
Q2
$1.43M Buy
6,818
+69
+1% +$14.7K 1.59% 27
2022
Q1
$1.64M Buy
6,749
+27
+0.4% +$6.53K 1.52% 29
2021
Q4
$1.75M Sell
6,722
-75
-1% -$19.5K 1.31% 32
2021
Q3
$1.79M Buy
6,797
+487
+8% +$133K 1.44% 29
2021
Q2
$1.56M Buy
6,310
+106
+2% +$22.3K 1.34% 31
2021
Q1
$1.2M Sell
6,204
-1,631
-21% -$327K 1.06% 43
2020
Q4
$1.67M Buy
+7,835
New +$1.56M 1.68% 23
2018
Q4
Sell
-1,750
Closed -$202K 58
2018
Q3
$202K Buy
+1,750
New +$192K 0.31% 57

Other funds holding RMD

Terra Nova Asset Management's RMD Position: Q1 2026 in Review

Terra Nova Asset Management reduced its ResMed (RMD) stake by 1.7% in Q1 2026, selling an estimated $32.6K and leaving 7,450 shares worth $1.67M. The position accounts for 1.24% of the portfolio, ranked #38.

Terra Nova Asset Management first reported a position in RMD in Q3 2018 and has held it in 23 quarters since. The position peaked at $2.14M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Terra Nova Asset Management held 7,450 shares of ResMed worth $1.67M as of Q1 2026.
  • Terra Nova Asset Management sold 131 ResMed shares in Q1 2026, an estimated $32.6K.
  • ResMed made up 1.24% of Terra Nova Asset Management's portfolio in Q1 2026, its #38 holding.
  • Terra Nova Asset Management first reported a position in ResMed in Q3 2018 and has held it in 23 quarters since.
  • Terra Nova Asset Management's ResMed position peaked at $2.14M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Terra Nova Asset Management's 13F filing for Q1 2026, filed 16 Apr 2026.